Listar Artículos (Química Orgánica) por agencia financiadora 

Listar Artículos (Química Orgánica) por agencia financiadora "Dirección General de Investigación (DGI). España"

Mostrando ítems 1-4 de 4

    • Artículo
      Icon

      Alkoxyamine-cyanoborane adducts: Efficient cyanoborane transfer agents 

      Márquez, José M.; Martínez Castro, Elisa; Gabrielli, Serena; López López, Óscar; Maya Castilla, Inés; Angulo, Manuel; Álvarez, Eleuterio; Fernández-Bolaños Guzmán, José María (Royal Society of Chemistry, 2011)
      We report the synthesis of the hitherto unknown zwitterionic alkoxyamino cyanoboranes by reduction of O-alkyloximes with ...
    • Artículo
      IconIcon

      New tacrine dimers with antioxidant linkers as dual drugs: Anti-Alzheimer's and antiproliferative agents 

      Roldán Peña, Jesús Miguel; Alejandre Ramos, Daniel; López López, Óscar; Maya Castilla, Inés; Lagunes, Irene; Padrón, José M.; Peña Altamira, Luis Emiliano; Bartolini, Manuela; Monti, Barbara; Bolognesi, Maria L.; Fernández-Bolaños Guzmán, José María (Elsevier, 2017)
      We have designed a series of tacrine-based homo- and heterodimers that incorporate an antioxidant tether (selenoureido, ...
    • Artículo
      Icon

      Tacrine-sugar mimetic conjugates as enhanced cholinesterase inhibitors 

      Oliveira de Santana, Quelli Larissa; Santos Evangelista, Tereza C.; Imhof, Petra; Ferreira, Sabrina Baptista; Fernández-Bolaños Guzmán, José María; Sydnes, Magne O.; López López, Óscar; Lindback, Emil (Royal Society of Chemistry, 2021-03-14)
      We have used the Cu(i)-catalyzed azide-alkyne Huisgen cycloaddition reaction to obtain two families of bivalent heterodimers ...
    • Artículo
      Icon

      Tuning the activity of iminosugars: novel N-alkylated deoxynojirimycin derivatives as strong BuChE inhibitors 

      Ahuja Casarín, Ana I.; Merino Montiel, Penélope; Vega Báez, José Luis; Montiel Smith, Sara; Fernandes, Miguel X,; Lagunes, Irene; Maya Castilla, Inés; López López, Óscar; Fernández-Bolaños Guzmán, José María (Taylor & Francis Open Access, 2021)
      We have designed unprecedented cholinesterase inhibitors based on 1-deoxynojirimycin as potential anti-Alzheimer’s agents. ...